257 related articles for article (PubMed ID: 21685375)
21. Roles of FHIT and WWOX fragile genes in cancer.
Iliopoulos D; Guler G; Han SY; Druck T; Ottey M; McCorkell KA; Huebner K
Cancer Lett; 2006 Jan; 232(1):27-36. PubMed ID: 16225988
[TBL] [Abstract][Full Text] [Related]
22. Expression of WWOX and FHIT is downregulated by exposure to arsenite in human uroepithelial cells.
Huang YC; Hung WC; Chen WT; Yu HS; Chai CY
Toxicol Lett; 2013 Jul; 220(2):118-25. PubMed ID: 23618899
[TBL] [Abstract][Full Text] [Related]
23. Gene essentiality landscape and druggable oncogenic dependencies in herpesviral primary effusion lymphoma.
Manzano M; Patil A; Waldrop A; Dave SS; Behdad A; Gottwein E
Nat Commun; 2018 Aug; 9(1):3263. PubMed ID: 30111820
[TBL] [Abstract][Full Text] [Related]
24. Epstein-Barr virus latent gene expression in primary effusion lymphomas containing Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8.
Horenstein MG; Nador RG; Chadburn A; Hyjek EM; Inghirami G; Knowles DM; Cesarman E
Blood; 1997 Aug; 90(3):1186-91. PubMed ID: 9242551
[TBL] [Abstract][Full Text] [Related]
25. Concordant loss of fragile gene expression early in breast cancer development.
Guler G; Uner A; Guler N; Han SY; Iliopoulos D; McCue P; Huebner K
Pathol Int; 2005 Aug; 55(8):471-8. PubMed ID: 15998374
[TBL] [Abstract][Full Text] [Related]
26. Common fragile genes and digestive tract cancers.
Kuroki T; Tajima Y; Furui J; Kanematsu T
Surg Today; 2006; 36(1):1-5. PubMed ID: 16378185
[TBL] [Abstract][Full Text] [Related]
27. Human herpes virus 8-unrelated primary effusion lymphoma-like lymphoma in the pericardium: A case with latency type III Epstein-Barr virus infection showing good prognosis without chemotherapy.
Nakamura H; Tsuta K; Nakagawa T; Hirai R; Ota Y
Pathol Res Pract; 2015 Dec; 211(12):1010-3. PubMed ID: 26384578
[TBL] [Abstract][Full Text] [Related]
28. Mutual inhibition between Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus lytic replication initiators in dually-infected primary effusion lymphoma.
Jiang Y; Xu D; Zhao Y; Zhang L
PLoS One; 2008 Feb; 3(2):e1569. PubMed ID: 18253508
[TBL] [Abstract][Full Text] [Related]
29. Common fragile site tumor suppressor genes and corresponding mouse models of cancer.
Drusco A; Pekarsky Y; Costinean S; Antenucci A; Conti L; Volinia S; Aqeilan RI; Huebner K; Zanesi N
J Biomed Biotechnol; 2011; 2011():984505. PubMed ID: 21318118
[TBL] [Abstract][Full Text] [Related]
30. Characterization of a novel HHV-8-positive cell line reveals implications for the pathogenesis and cell cycle control of primary effusion lymphoma.
Carbone A; Cilia AM; Gloghini A; Capello D; Fassone L; Perin T; Rossi D; Canzonieri V; De Paoli P; Vaccher E; Tirelli U; Volpe R; Gaidano G
Leukemia; 2000 Jul; 14(7):1301-9. PubMed ID: 10914556
[TBL] [Abstract][Full Text] [Related]
31. KSHV-infected PEL cell lines exhibit a distinct gene expression profile.
Ueda K; Ito E; Karayama M; Ohsaki E; Nakano K; Watanabe S
Biochem Biophys Res Commun; 2010 Apr; 394(3):482-7. PubMed ID: 20175997
[TBL] [Abstract][Full Text] [Related]
32. Expression of common chromosomal fragile site genes, WWOX/FRA16D and FHIT/FRA3B is downregulated by exposure to environmental carcinogens, UV, and BPDE but not by IR.
Thavathiru E; Ludes-Meyers JH; MacLeod MC; Aldaz CM
Mol Carcinog; 2005 Nov; 44(3):174-82. PubMed ID: 16187332
[TBL] [Abstract][Full Text] [Related]
33. Multiple viral infections in primary effusion lymphoma: a model of viral cooperation in lymphomagenesis.
Gloghini A; Volpi CC; Gualeni AV; Dolcetti R; Bongarzone I; De Paoli P; Carbone A
Expert Rev Hematol; 2017 Jun; 10(6):505-514. PubMed ID: 28468596
[TBL] [Abstract][Full Text] [Related]
34. Human Herpesvirus Type 8-associated Large B-cell Lymphoma: A Nonserous Extracavitary Variant of Primary Effusion Lymphoma in an HIV-infected Man: A Case Report and Review of the Literature.
Foster WR; Bischin A; Dorer R; Aboulafia DM
Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):311-21. PubMed ID: 27234438
[TBL] [Abstract][Full Text] [Related]
35. Interleukin 1 receptor-associated kinase 1 (IRAK1) mutation is a common, essential driver for Kaposi sarcoma herpesvirus lymphoma.
Yang D; Chen W; Xiong J; Sherrod CJ; Henry DH; Dittmer DP
Proc Natl Acad Sci U S A; 2014 Nov; 111(44):E4762-8. PubMed ID: 25341731
[TBL] [Abstract][Full Text] [Related]
36. Alterations of mRNA splicing in primary effusion lymphomas.
Li Z; Pan L; Cesarman E; Knowles DM
Leuk Lymphoma; 2003 May; 44(5):833-40. PubMed ID: 12802923
[TBL] [Abstract][Full Text] [Related]
37. Evidence for a Mesothelial Origin of Body Cavity Effusion Lymphomas.
Sanchez-Martin D; Uldrick TS; Kwak H; Ohnuki H; Polizzotto MN; Annunziata CM; Raffeld M; Wyvill KM; Aleman K; Wang V; Marshall VA; Whitby D; Yarchoan R; Tosato G
J Natl Cancer Inst; 2017 Sep; 109(9):. PubMed ID: 28376153
[TBL] [Abstract][Full Text] [Related]
38. Loss expression of active fragile sites genes associated with the severity of breast epithelial abnormalities.
Wang TT; Frezza EE; Ma R; Hu SY; Liu CZ; Zhang GY; Wachtel MS; Lü XM; Feng JB; Lü CX
Chin Med J (Engl); 2008 Oct; 121(20):1969-74. PubMed ID: 19080258
[TBL] [Abstract][Full Text] [Related]
39. Kaposi's Sarcoma-Associated Herpesvirus Drives a Super-Enhancer-Mediated Survival Gene Expression Program in Primary Effusion Lymphoma.
Manzano M; Günther T; Ju H; Nicholas J; Bartom ET; Grundhoff A; Gottwein E
mBio; 2020 Aug; 11(4):. PubMed ID: 32843547
[TBL] [Abstract][Full Text] [Related]
40. Large common fragile site genes and cancer.
Smith DI; McAvoy S; Zhu Y; Perez DS
Semin Cancer Biol; 2007 Feb; 17(1):31-41. PubMed ID: 17140807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
